AL3 18.4% 15.5¢ aml3d limited

Ann: AML3D to Establish USA Facility following Capital Raise, page-13

  1. 82 Posts.
    lightbulb Created with Sketch. 31
    Presentation is interesting, as it now gives us a view on the financials behind Archemy unit sales and the longer term business model.

    Sales of $2M Archemy unit comes with a trailing REVENUE of $250K per year with software licensing, maintenance and production support.

    Assume there is only a small profit margin on maintenance / support and this will not make a tangible difference to the business profitability regardless of the number of Archemy units sold.

    Real kicker is the software licensing. For a small number of units probably does not cover current software development costs. However with every extra Archemy unit sold, this presumably become the real profit centre. As software costs will effectively be fixed and is not tied to number of machines.

    Hopefully with a base in US they can more effectively achieve more Archemy unit sales.
    Last edited by bjk007: 03/04/24
 
watchlist Created with Sketch. Add AL3 (ASX) to my watchlist
(20min delay)
Last
15.5¢
Change
-0.035(18.4%)
Mkt cap ! $58.45M
Open High Low Value Volume
19.0¢ 19.5¢ 15.5¢ $1.682M 9.747M

Buyers (Bids)

No. Vol. Price($)
4 431580 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.0¢ 234268 10
View Market Depth
Last trade - 13.47pm 16/07/2024 (20 minute delay) ?
AL3 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.